ATS 2019 Virtual Final Program

BEHAVIORAL • CLINICAL RAPID: RAPID ABSTRACT POSTER DISCUSSION SESSION D110 LUNG CANCER: OPTIMIZING SCREENING, DIAGNOSIS, AND TREATMENT 1:30 p.m. - 3:30 p.m. KBHCCD Arena (Level 2) Abstract Summaries 1:30-2:00 Viewing/Discussion 2:00-3:30 Chairing: H.C. Cain, MD, MS, New Haven, CT V.S. Nair, MSCR, MD, Tampa, FL M.B. Schabath, PhD, Tampa, FL 401 Fish Intake, Dietary Polyunsaturated Fatty Acids, and Lung Cancer: Systematic Review and Dose-Response Meta-Analysis of 1.7 Million Men and Women/ C. Cao, N. Xu, Ningbo, China, p.A7277 402 The Effect of Coordinated Investigations for Rural Lung Cancer Patients on Traveling and Time to Staging Completion/ S. Naqvi, S. Bharadwaj, R. Kennedy, R. Bigsby, P. Babyn, C.C. Tyan, Saskatoon, Canada, p.A7278 403 Differences in Utilization of Resources for Grief Management in Lung Cancer Patients with and Without Previous Psychiatric Illness Seeking Care at a National Cancer Institute Designated Cancer Center in New Mexico/ E. Sheehan, A.E. Wright, L.N. Stalter, F. Qeadan, C. Wiggins, A.I. Saeed, Albuquerque, NM, p.A7279 404 Use of Awake Video Assisted Thoracic Surgery (AVATS) in Complex Thoracic Cases- Evolution of a New Technique to Improve Outcomes/ A. Klijian, San Diego, CA, p.A7280 405 Quantitative Coronary Artery Calcium Score Is Associated with the Development of Lung Cancer/ W. Long, A. Sanayei, W. Thedinger, C. Stefanescu, G. Rizzo, S. Regis, A. McKee, B.J. McKee, C. Wald, L. Gazourian, Boston, MA, p.A7281 406 Handgrip Weakness and Low Fat-Free Mass Are Prognostic Factors for Overall Survival in Patients with Non-Small Cell Lung Cancer Treated with Curative-Intent Radiotherapy/ C. Burtin, Diepenbeek, Belgium, p.A7282 407 Evaluate and Compare Incidence of Pneumonitis Associated with Nivolumab, Pembrolizumab, Atezolizumab and Durvalumab Used in Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer/ H. Abid, A. Shukla, M. Hetavi, G. Bharatsinh, Cooperstown, NY, p.A7283 408 Incidence and Outcomes of Patients with Metastatic Lung Cancer Requiring Mechanical Ventilation/ H.-I. Liao, S.B. Smith, Chicago, IL, p.A7284 409 Long-Term Cardiovascular Risk Following Radiation Therapy in Lung Cancer/ B. Liu, D. Marshall, K. Rosenzweig, J. Kong, J.P. Wisnivesky, K. Sigel, New York, NY, p.A7285 410 MAP THE GAP: Mapping the Incidence and Mortality of Lung Cancer to Physician Distribution Across the United States/ A. Fatima, N. Anand, Q. Mehdi, Z. Hussain, M. Rachid, A. Krikorian, Oak Lawn, IL, p.A7286 411 Neighborhood Disadvantage and Lung Cancer Incidence in an Electronic Health Record Cohort/ Y. Adie, A. Tlimat, D. Kats, A. Perzynski, Y. Tarabichi, Los Angeles, CA, p.A7287 412 Lung Cancer Screening in Academic and Community Practice: A Tale of Two Cities/ L.M. Henderson, S. Sites, T.D. Tailor, S.C. Bearden, R. Huamani, A. Throneburg, M.P. Rivera, Chapel Hill, NC, p.A7288 413 Quality Elements for Lung Cancer Screening Programs: The Struggle for Implementation in the Community/ C. Henson, C.L. Wilshire, S.R. Epstein, C.R. Gilbert, E.H. Vallieres, J.A. Gorden, Seattle, WA, p.A7289 414 Impact of Time Exposure to Renin-Angiotensin Blockers on Survival of Patients with Localized Non-Small Cell Lung Cancer/ M.J. Pereira Catarata, R. Ribeiro, C. Robalo Cordeiro, Coimbra, Portugal, p.A7290 415 Positive PD-L1 Expression Is Associated with Unfavorable Clinical Outcome in EGFR-Mutated Lung Adenocarcinomas Treated with EGFR-TKIs/ W. Jeon, B. Lim, S.W. Han, W.G. Kwack, B. Chang, H. Choi, Y.H. Kim, C.W. Choi, M.J. Park, J.-H. Yoo, S.H. Lee, Seoul, Korea, Republic of, p.A7291 416 Co-Expression of Programmed Death-Ligand 1 (PD-L1) Expression in EGFR Mutant Stage IV Lung Adenocarcinoma/ P.C. Hsu, C.-W. Wang, S.C.-H. Kuo, C.-T. Yang, Taoyuan County, Taiwan, p.A7292 417 Epigenetic Effects of Iloprost and Regulation of Frizzled9 in Lung Cancer Chemoprevention/ M. Tennis, P. Do, D. McArthur, L.D. Nield, R.L. Keith, Aurora, CO, p.A7293 418 Patterns of Guideline Adherence in Patients Found to Have a Solid Pulmonary Nodule/ J. Akulian, D. Odey Erim, D. Reuland, A. Brenner, P. Fleming, K. Kim, M. Sakthivel, J. Elston Lafata, Chapel Hill, NC, p.A7294 419 CT-Guided Lung Biopsies: 18 Gauge vs 20 Gauge Needle Size on Rates of Pneumothorax and Sample Adequacy/ N. Kolderman, D. Cheti, C. Hasbrook, A. Forsyth, M. Coffey, G. Nair, S. Al-Katib, Royal Oak, MI, p.A7295 ATS 2019 • Dallas, TX WEDNESDAY • MAY 22 391 WEDNESDAY AFTERNOON